(0.87%) 5 126.50 points
(0.22%) 38 373 points
(1.12%) 17 765 points
(0.50%) $83.99
(-2.08%) $1.604
(0.34%) $2 350.40
(0.98%) $27.62
(1.30%) $932.50
(0.05%) $0.932
(0.06%) $10.96
(0.03%) $0.800
(0.03%) $92.20
Live Chart Being Loaded With Signals
AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and oncology. The company is developing rapid diagnostic tests, which measure the levels of functional neutralizing antibodies that prevent SARS-CoV-2 from attaching to human cells; serological diagnostic test, which detect neutralizing antibodies that measure adaptive immune response to the SARS-CoV-2 virus; and tests for management of COVID-19 Patients to detect biomarkers related to inflammation...
Stats | |
---|---|
Today's Volume | 2.05M |
Average Volume | 523 835 |
Market Cap | 3.41M |
EPS | $0.000690 ( 2023-11-20 ) |
Next earnings date | ( $0 ) 2024-05-22 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.310 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-15 | Huemoeller John Walter Ii | Buy | 250 000 | Convertible Note |
2024-03-15 | Valencia Catalina | Buy | 7 837 500 | Convertible Note |
2024-03-15 | Schroeder Blake | Buy | 35 000 | Convertible Note |
2024-03-15 | Cunningham Robert L | Buy | 35 000 | Convertible Note |
2024-03-15 | Scott Timothy Richard | Buy | 35 000 | Convertible Note |
INSIDER POWER |
---|
100.00 |
Last 56 transactions |
Buy: 36 148 017 | Sell: 23 000 000 |
AXIM Biotechnologies, Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
AXIM Biotechnologies, Financials
Annual | 2023 |
Revenue: | $39 518.00 |
Gross Profit: | $-387 501 (-980.57 %) |
EPS: | $-0.0354 |
Q4 | 2023 |
Revenue: | $12 859.00 |
Gross Profit: | $-93 896.00 (-730.20 %) |
EPS: | $-0.00790 |
Q3 | 2023 |
Revenue: | $9 581.00 |
Gross Profit: | $-97 174.00 (-1 014.24 %) |
EPS: | $0.00140 |
Q2 | 2023 |
Revenue: | $9 929.00 |
Gross Profit: | $-96 826.00 (-975.18 %) |
EPS: | $-0.0165 |
Financial Reports:
No articles found.
AXIM Biotechnologies,
AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and oncology. The company is developing rapid diagnostic tests, which measure the levels of functional neutralizing antibodies that prevent SARS-CoV-2 from attaching to human cells; serological diagnostic test, which detect neutralizing antibodies that measure adaptive immune response to the SARS-CoV-2 virus; and tests for management of COVID-19 Patients to detect biomarkers related to inflammation. It is also developing rapid quantitative tear tests for Matrix metalloproteinase-9, an inflammatory biomarker for dry eye disease; SBI-183, an anti-metastatic compound suppressing tumor cell growth and blocking metastasis; and SPX-1009, an anti-metastatic treatment to measure levels of quiescin sulfhydryl oxidase I. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators